Virtuix delivered its Omni One omni-directional treadmill to Florida Gulf Coast University on April 14, 2026. The university’s College of Health & Human Services will evaluate the system for physical therapy, neurological rehabilitation, and clinical simulation. The assessment focuses on the device's ability to monitor gait, balance, and postural control.
This initiative marks a strategic expansion into the healthcare sector, adding to the company's established consumer and defense business. CEO Jan Goetgeluk stated the collaboration will test the Omni One’s viability for medical applications.
Market reaction to the announcement was negligible. Trading volume remained muted leading up to the news, suggesting the strategic shift was not widely anticipated by investors.